Cargando…
Interleukin-17A promotes functional activation of systemic sclerosis patient-derived dermal vascular smooth muscle cells by extracellular-regulated protein kinases signalling pathway
INTRODUCTION: Dermal vascular smooth muscle cells (DVSMCs) are important for vascular wall fibrosis in microangiopathy of systemic sclerosis (SSc). T helper 17 cell-associated cytokines, particularly interleukin-17A (IL-17A), have been demonstrated to play a role in the pathogenesis of SSc. However,...
Autores principales: | Liu, Mengguo, Yang, Ji, Xing, Xiaojing, Cui, Xiangxiang, Li, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316765/ https://www.ncbi.nlm.nih.gov/pubmed/25551434 http://dx.doi.org/10.1186/s13075-014-0512-2 |
Ejemplares similares
-
Tanshinone IIA attenuates interleukin-17A-induced systemic sclerosis patient-derived dermal vascular smooth muscle cell activation via inhibition of the extracellular signal-regulated kinase signaling pathway
por: Liu, Mengguo, et al.
Publicado: (2015) -
Effect of crosstalk between Th17 and Th9 cells on the activation of dermal vascular smooth muscle cells in systemic scleroderma and regulation of tanshinone IIA()
por: Liu, Mengguo
Publicado: (2022) -
Interleukin-17 Reduces βENaC via MAPK Signaling in Vascular Smooth Muscle Cells
por: Duncan, Jeremy W., et al.
Publicado: (2020) -
Human interleukin 1 induces interleukin 1 gene expression in human vascular smooth muscle cells
Publicado: (1987) -
Engineering Smooth Muscle to Understand Extracellular Matrix Remodeling and Vascular Disease
por: Yarbrough, Danielle, et al.
Publicado: (2022)